Atlas Trials

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi

Clinical trial NCT03130426 · COMPLETED

Trial details

NCT number
NCT03130426
Sponsor
Population Health Research Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2017-06-27
Primary completion
2019-06-30
Enrollment
161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.